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Abstract 
Background: Wheezing affects children’s quality of life, and is related with asthma in 
childhood. Although prevalence of wheezing has been previously studied in several countries, 
there are no reference of worldwide prevalence in infants. The aim of this meta-analysis is to 
estimate the prevalence of wheezing and recurrent wheezing in infants aged up to two years, 
and compare the prevalence across world regions. 
Methods: Literature search was conducted in MEDLINE and SCOPUS databases, looking for 
observational studies published up to June 2016, including as keywords “prevalence” or 
“epidemiology” combined with “wheeze”, “wheezing” or “asthma symptoms” and “infant” or 
“preschool”. Fast*Pro software and random effects Bayesian model were used. Heterogeneity 
was estimated using I2 statistic, and sensitivity analyses were performed. 
Results: We identified 109 studies after duplicates were removed. After exclusions, 14 studies 
were included in the meta-analysis. Prevalence of wheezing and recurrent wheezing were 36.06% 
(95% CI 35.17-36.96), and 17.41% (95% CI 16.74-18.09), respectively. In European countries, 
prevalence of wheezing was 30.68% (95% CI 28.97-32.45), and 12.35% (95% CI 11.27-13.47) 
for recurrent wheezing. Prevalence of wheezing and recurrent wheezing in Latin America were 
higher, 40.55% (95% CI 39.40-41.71), and 19.27% (95% CI 18.44-20.11), respectively. In 
Africa, prevalence of wheezing was 15.97% (95% CI 14.05-18.00). Low or no heterogeneity 
was found in all cases. 
Conclusions: More than one third of infants suffer from wheezing and almost one fifth from 
recurrent wheezing, being these illnesses especially prevalent in Latin American countries, 
pointing out an important public health problem. 
Keywords: epidemiology, infants, meta-analysis, prevalence, recurrent wheezing, wheezing  
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INTRODUCTION 
Wheezing in infants not only affects children’s quality of life (1), but is related to the 
development of asthma childhood (2). Several risk factors, as viral respiratory infections (3), 
prenatal and postnatal tobacco smoke exposure (4), familiar history of asthma (5), or pollution 
(6) have been previously identified. 
Prevalence of asthma and wheezing in schoolchildren and adolescents has been studied 
in the past. The International Study of Asthma and Allergies in Childhood (ISAAC) found 
highest prevalence of wheezing in children in United Kingdom, Oceania and Latin American 
countries (7). In the Phase III of the same study, increasing trends were found in countries which 
showed lower prevalence in Phase I, while in the Oceanian countries decreasing trends were 
found (8). 
More recently, the International Study of Wheezing in Infants (Estudio Internacional de 
Sibilancias en Lactantes in Spanish, or EISL), a multicentre study in European and Latin 
American countries, was conducted to determine the prevalence, severity and risk factors for 
wheezing in infants (9). 
However, no previous studies about the worldwide prevalence of wheezing in infants 
have been conducted. Therefore, the aim of this meta-analysis is to estimate the prevalence of 
wheezing and recurrent wheezing in infants aged up to two years, and compare the prevalence 
across different world regions. 
MATERIALS AND METHODS 
This meta-analysis has been conducted according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement (10), and its protocol has been 
registered in PROSPERO (reference CRD42016039446). 
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Search strategy and selection criteria 
The literature search was performed in MEDLINE and SCOPUS databases, looking for 
observational studies published up to June 2016.  
Search terms were “prevalence” or “epidemiology” (title), combined with “wheeze”, 
wheezing” or “asthma symptoms” (title), and “infant” or “preschool” (topic). The search terms 
were combined with Boolean search function “and”. No language filters were used. 
Studies were included in the meta-analysis if they met the following criteria: 1) Original 
community-based studies; 2) Participants aged up to 2 years; 3) Wheezing and/or recurrent 
wheezing were defined; 4) Provided original data on the prevalence of wheezing and/or 
recurrent wheezing. 
The search was complemented by reviewing the references of the selected articles to 
identify additional studies. In those cases that we could not have technical access, we requested 
the article through the Public University of Navarre library to other institutions. Two 
researchers (I.A.A. and H.N.) conducted the search and evaluate the studies, resolving the 
discrepancies by discussion. 
After excluding duplicates, 109 articles were found. Reviews, pool studies, studies 
which not provided wheezing cases or its study population was older than two years were 
excluded. Abstracts and non-published studies were also excluded. 
Studies quality was assessed using the Quality Assessment Tool for Observational and 
Cross-Sectional Studies, developed by the National Heart, Lung and Blood Institute (NHLBI) 
(11). We assigned one point to positive answers, and zero points to negative answers, 
calculating the percentage.  
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Low, medium and high quality studies were those which scored less than 50%, between 
50% and 75%, and more than 75%, respectively. Low quality studies were removed from the 
analysis. 
Data extraction 
Two researchers (I.A.A. and H.N.) conducted the data extraction, resolving the 
differences by consulting other researcher (F.G.G.). The following data were recorded from 
each article: 1) Author’s name and year of publication; 2) Country where the study was 
conducted; 3) Definition of wheezing and/or recurrent wheezing; 4) Age range; 5) Number of 
participants in the study; 6) Wheezing and/or recurrent wheezing cases. 
Quantitative analysis (meta-analysis) 
Separate meta-analyses were conducted for wheezing and recurrent wheezing in infants. 
Besides, we conducted additional meta-analyses for world regions (Europe, Latin America and 
Africa). Fast*Pro software was used to make the calculations. We used a random effects 
Bayesian model, showing 95% credibility intervals (95% CI). 
In Bayesian analysis, credibility intervals are different from confidence intervals of the 
frequentist statistics. 95% credible interval means that the probability that the real value is in 
the range of the 95%, according to our initial belief and the observed data. However, a 95% 
confidence interval indicates that in many repeated samples, 95% of the intervals will show a 
true value. 
Sensitivity analyses were performed, replicating the results after excluding studies with 
the lowest and highest prevalence, to study the robustness of the analysis and the influence of 
the removed study. To estimate the heterogeneity, I2 statistic was used, estimating the 
percentage of total variability between studies explained by heterogeneity (12). 
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The risk of publication bias was assessed graphically by a funnel plot. 
Although no wheezing definition were specified, Dela Bianca et al (18), Ferreira et al 
(23) and Moraes et al (24) used the written questionnaire from the EISL study, considering 
wheezing definitions from this questionnaire (13). Bueso et al (17) provided data from both 
Honduras and El Salvador EISL studies, which were separately included in this meta-analysis. 
Recurrent wheezing was defined as three or more episodes of wheezing by all the studies. 
RESULTS 
We identified 148 studies (94 in MEDLINE and 54 in SCOPUS). After duplicates were 
removed, we reviewed 109 studies. We excluded 59 studies whose title and/or abstract were 
not relevant (47 in MEDLINE and 12 in SCOPUS). Of the remaining 50 studies, 14 studies 
were excluded because they were reviews or pooled studies, studied risk factors for wheezing 
but did not provide prevalence data, did not define the outcome or provide wheezing cases, and 
were not community-based studies (14 in MEDLINE), and 28 were excluded because their 
study population was older than two years old (25 in MEDLINE and 3 in SCOPUS). Finally, 
eight studies were included (15, 16, 18-20, 22-24). 
After examining the studies included, we identified and added six studies from the 
references (14, 17, 21, 25, 26). Finally, 14 studies were included in the meta-analysis. (Figure 
1) Of these, 11 defined and provided recurrent wheezing cases, and were included in the meta-
analysis of recurrent wheezing. 
Study characteristics are shown in Table 1. Studies were conducted in Brazil, Honduras, 
El Salvador, Spain, Netherlands, Ethiopia and Tanzania. All were cohort studies, population 
ranged between 673 and 3003 subjects, and their participants’ age ranged between 12 and 24 
months.
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Table 1. Characteristics of the studies included in the meta-analysis. 
Author, year Country Wheezing definition RW definition 
Sunyer et al, 2001 (14) Tanzania Has your child ever been wheezing or whistling in the chest? - 
Chong Neto et al, 2007 (15) Brazil Has your baby had wheezing in the chest or bronchitis or whistling during his/her 
first 12 months of life? 
3 or more 
episodes 
Belyhun et al, 2010 (16) Ethiopia Has your child ever had wheezing or whistling in their chest? - 
Bueso et al, 2010 (17) Honduras Has your child had wheezing or whistling in the chest  
during the 12 months of his/her life?  
3 or more 
episodes 
Bueso et al, 2010 (17) El Salvador Has your child had wheezing or whistling in the chest  
during the 12 months of his/her life?  
3 or more 
episodes 
Dela Bianca et al, 2010 (18) Brazil Has your baby had wheezing or whistling in the chest  
during his/her 12 months of life?  
3 or more 
episodes 
Visser et al, 2010 (19) Netherlands Has your child ever wheezed during the first twelve months of his/her life? 3 or more 
episodes 
Medeiros et al, 2011 (20) Brazil Has your baby had wheezing in the chest or bronchitis  
or whistling during his/her first 12 months of life? 
- 
Pellegrini-Belinchon  
et al, 2012 (21) 
Spain Has your child experienced wheezing or whistling in the chest  
in the first 12 months of life? 
3 or more 
episodes 
Costa Bessa et al, 2014 (22) Brazil Presence of wheezing or bronchitis in the first 12 months of child’s life 3 or more 
episodes 
Ferreira et al, 2014 (23) Brazil Has your baby had wheezing or whistling in the chest or bronchitis 
 in the last 12 months? 
3 or more 
episodes 
Moraes et al, 2014 (24) Brazil Has your baby ever wheezed in the first 12 months of life? 3 or more 
episodes 
Bercedo-Sanz et al, 2015 
(25) 
Spain Has your child experienced wheezing or whistling sounds in the chest in the first 12 
months of life? 
3 or more 
episodes 
Alvarez-Alvarez et al, 2016 
(26) 
Spain Has your child wheeze in the first 12 months of his/her life? 3 or more 
episodes 
RW: recurrent wheezing 
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Quality assessment showed four studies (18,20,21,25) with medium quality, and the rest 
(14-17, 19, 22-24, 26) with high quality. Therefore, no studies were removed from the analysis. 
Results of the meta-analysis of wheezing and recurrent wheezing are presented in Table 
2 and Figure 2. The prevalence of wheezing in infants was 36.06% (95% CI 35.17-36.96). No 
heterogeneity between the studies was found (I2<0). Sensitivity analyses were conducted, 
removing the Ferreira et al study (23), finding the prevalence was 35.27% (95% CI 34.36-
36.19), with no heterogeneity (I2<0). On the other hand, when the Belyhun et al study (16) was 
excluded, prevalence was 37.42% (95% CI 36.48-38.36), showing a low heterogeneity 
(I2=5.98). 
The prevalence of recurrent wheezing was 17.41% (95% CI 16.74-18.09). The estimated 
heterogeneity was I2=15.81, a low heterogeneity. When sensitivity analyses were conducted, 
prevalence of recurrent wheezing did not vary substantially. Prevalence when the Dela Bianca 
et al study (18) was removed from the analysis was 16.72% (95% CI 16.04-17.42), finding low 
heterogeneity (I2=3.15). When we excluded the Alvarez-Alvarez et al study (26), prevalence 
was 18.00% (95% CI 17.29-18.73), also showing a low heterogeneity (I2=18.72). 
Results of the meta-analyses of prevalence of wheezing across regions (Europe, Latin 
America and Africa) are shown in Figure 3. In European countries, prevalence of wheezing 
and recurrent wheezing were 30.68% (95% CI 28.97-32.45) and 12.35% (95% CI 11.27-13.47), 
respectively. In both cases, no heterogeneity was revealed (I2<0). In Latin America, prevalence 
of wheezing, 40.55% (95% CI 39.40-41.71), and recurrent wheezing, 19.27% (95% CI 18.44-
20.11), were higher than in Europe, showing a low heterogeneity (I2=7.65, and I2=7.30, 
respectively). In African countries, prevalence of wheezing in infants was 15.97% (95% CI 
14.05-18.00), not evidencing heterogeneity (I2<0). 
The funnel plot did not indicate publication bias (Figure 4).
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Table 2. Meta-analysis of the prevalence of wheezing and recurrent wheezing in infants. 
   Wheezing  Recurrent wheezing 
Author Age range  Cases Population Prevalence (95% CI)  Cases Population Prevalence (95% CI) 
Sunyer et al (14) 18 months  148 673 22.07% (18.66-25.75)  - - - 
Chong Neto et al (15) 12-15 months  1364 3003 45.44% (43.06-47.88)  678 3003 22.59% (20.93-24.33) 
Belyhun et al (16) 1 year  103 899 11.51% (9.40-13.83)  - - - 
Bueso et al (Honduras) (17) 12-15 months  216 780 27.76% (24.18-31.57)  91 780 11.73% (9.45-14.25) 
Bueso et al (El Salvador) (17) 12-15 months  431 1047 41.21% (37.42-45.19)  193 1047 18.48% (15.97-21.18) 
Dela Bianca et al (18) 12-15 months  467 1014 46.11% (42.02-50.38)  270 1014 26.68% (23.59-29.95) 
Visser et al (19) 13 months  312 1115 28.03% (25.01-31.22)  149 1115 13.41% (11.35-15.64) 
Medeiros et al (20) 12-15 months  466 1071 43.56% (39.69-47.60)  - - - 
Pellegrini-Belinchon et al (21) 12 months  242 750 32.33% (28.39-36.53)  89 750 11.93% (9.59-14.53) 
Costa-Bessa et al (22) 12-15 months  1024 2732 37.50% (35.24-39.83)  444 2732 16.27% (14.79-17.82) 
Ferreira et al (23) 12-24 months  499 1028 48.59% (44.42-52.94)  246 1028 23.98% (21.08-27.06) 
Moraes et al (24) 12-15 months  294 1060 27.78% (24.70-31.05)  135 1060 12.78% (10.72-15.02) 
Bercedo-Sanz et al (25) 12-15 months  313 958 32.72% (29.20-36.45)  137 958 14.35% (12.05-16.85) 
Alvarez-Alvarez et al (26) 12-15 months  327 1065 30.75% (27.51-34.17)  106 1065 10.00% (8.19-11.99) 
          
Meta-analysis   6206 17095 36.06% (35.17-36.96)  2538 14552 17.41% (16.74-18.09) 
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DISCUSSION 
The present meta-analyses evidenced that wheezing in infants is a public health burden, 
affecting more than one third of infants, with nearly one fifth of infants who are recurrent 
wheezers, being these illnesses especially prevalent in Latin America. Sensitivity analyses did 
not substantially change the results when studies were removed, and there was no heterogeneity 
or was low, thus the meta-analysis seems to be robust. 
Previously global studies, as the Phase I and III of the ISAAC study, found a mean 
prevalence of wheezing in schoolchildren of 11.8% and 11.5%, respectively (7, 27), lower than 
our results. However, ISAAC study included much more centres than our analysis, and the 
higher incidence of wheezing in the first three years of life (28), could explain our results. 
A previous European study found higher prevalence of wheezing, ranging from 29% to 
48% in North and South European countries, respectively, in children aged 1-5 years (29). A 
possible reason to explain the differences might be its different study population and 
methodology. 
In Latin America, more than 40% of infants had wheezing in the first two years of life, 
and almost 20% were recurrent wheezers. Our results are slightly higher than others from a 
recent study, which found prevalences of wheezing and recurrent wheezing in the first year of 
life of 39.9% and 16.6%, respectively (30). 
Only two African studies were included in the meta-analysis. Prevalence of wheezing 
in this continent was almost 16%, higher than results from Phase III of ISAAC (27), although 
the low number of studies included could have led to a wrong estimation. 
The analysis showed differences in the prevalence of wheezing and recurrent wheezing 
across world regions, finding the highest prevalences in Latin America.  
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Garcia-Marcos et al found that socioeconomic factors had a major impact in this region 
(31). Lower parental education (32) and factors related with poverty, dirt and infections (33) 
have been also associated with higher prevalence of wheezing in children. 
Another explanation to the higher prevalence found in Latin America compared to 
Europe could be the African ancestry, which has been found as risk factor for recurrent 
wheezing (34). 
According to the World Health Organization, low and middle-income countries in Latin 
American region showed higher pollution levels than European high-income countries (35). 
Improvements in air quality are associated with an improved lung-function development (36), 
and consequently with a lower risk of asthma (37), which might be another possible reason. 
Parasitic infections with Ascaris lumbricoides and Trichuris trichiura have been 
described as risk factor for wheezing in Latin American infants (38). However, findings are 
controversial, with other studies conducted in Africa which found a reduced risk for the disease 
(39, 40), which might partially explain the differences in the prevalence between these regions. 
One of the strengths of this study is its novelty. As far as we know, there is no other 
meta-analysis which estimates the prevalence of wheezing in infants, providing original results 
with high-quality scientific evidence. Moreover, because of most of included studies defined 
the outcome according to the ISAAC or EISL language, the consistency of the definition is high. 
Our study also has some limitations. First, there are technical limitations. We could not 
access other databases, which might have limited our search and findings. Second, it lacks of 
data from more countries. Most of Latin American and European data were from Brazil and 
Spain, respectively, which might not be representative of their respective world regions. Third, 
only two African studies were included, and we could not find any studies conducted in Asian 
or Oceanian countries which met the criteria, which would have improved our analysis. 
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In conclusion, this meta-analysis estimate that wheezing and recurrent wheezing affect 
a high percentage of infants, especially in Latin American countries, who may develop asthma 
in later years, evidencing a public health burden. Further studies involving other countries and 
world regions and trends analyses would be helpful, and promoting measures addressed to 
preventable risk factors previously identified would be recommendable. 
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Figure 1. Flow chart of the study. 
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Figure 2. Meta-analysis of prevalence of wheezing (A) and recurrent wheezing (B). 
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Figure 3. Meta-analysis of wheezing in infants across regions. 
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Figure 4. Funnel plot. 
 
Legend 
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The points correspond to the data. The continuous line corresponds to the average. The 
dotted line and discontinuous line correspond to the 2 and 3 standard deviation limits, 
respectively. 
 
